Adverse Reactions from Clinical Trials: There are no data available on adverse reactions from Baxter-sponsored clinical trials conducted with HUMAN ALBUMIN.
Post-Marketing Adverse Reactions: The following adverse reactions have been reported in the post-marketing experience.
IMMUNE SYSTEM DISORDERS: Anaphylactic shock, Anaphylactic reaction, Hypersensitivity/Allergic reactions.
NERVOUS SYSTEM DISORDERS: Headache, Dsygeusia.
CARDIAC DISORDERS: Myocardial infarction, Atrial fibrillation, Tachycardia.
VASCULAR DISORDERS: Hypotension, Flushing.
RESPIRATORY, THORACIC, AND MEDIASTINAL DISORDERS: Pulmonary edema, Dyspnea.
GASTROINTESTINAL DISORDERS: Vomiting, Nausea.
SKIN AND SUBCUTANEOUS TISSUE DISORDERS: Urticaria, Rash, Pruritus.
GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS: Pyrexia, Chills.